Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit

Chinese Medical Journal

Volumn 114, Issue 9, 2001, Pages 972-975

  Yin, Lianhua ^a   Fu, Siqing ^b   Wang, Xinhong ^a   Nanakorn, T ^b   Won, Jongho ^b   Deisseroth, A ^b  

^a FUDAN UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 fluorocytosine; Cytosine deaminase; Gene therapy; Prostate cancer

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CYTOSINE DEAMINASE GENE; GENE; GENE EXPRESSION; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; SENSITIZATION; TUMOR GROWTH;

ADENOVIRIDAE; ANIMALS; ANTIMETABOLITES; BYSTANDER EFFECT; CELL SURVIVAL; CYTOSINE DEAMINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUCYTOSINE; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NUCLEOSIDE DEAMINASES; PROSTATIC NEOPLASMS; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSGENES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034816904     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer: multi-institutional analysis. JAMA 1996; 276: 615-619.
2. Huber BE, Austin EA, Good SS, et al. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res 1993; 53: 4619-4626.
3. Hoganson DK, Batra RK, Olsen JC, et al. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and by stander effect in lung adenocarcinoma. Cancer Res 1996; 56: 1315-1323.
4. Mullen C, Polak A, Scholer JG. Mode of action of 5-Fluorocytosine and mechanism of resistance. Chemotherapy 1975; 21: 113-130.
5. Pederson LC, Buchsbaum DJ, Vickers SM, et al. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res 1997; 57: 4325-4332.
6. Mullen C. Metabolic suicide genes in gene therapy. Pharmacol Ther 1994; 63: 199-207.
7. Kuriyama S, Masui K, Sakamoto T, et al. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Anticancer Res 1998; 18: 3399-3406.
8. Hanna NN, Mauccri HJ, Waync JD, et al. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhance radiation response in human cancer xenografts. Cancer Res 1997; 57: 4205-4209.
9. Szary J, Missol E, Tarnawski R, et al. Selective augmentation of radiation effects by 5-fluorocytosine on murine B16(F10) melanoma cells transfected with cytosine deaminase gene. Cancer Gene Ther 1997; 4: 269-272.